TrialSiteNews

“To think we’re going to boost our way out of this- is preposterous.” Dr David Wiseman I had the fortunate opportunity of interviewing Dr David Wiseman, a PhD research Bio scientist, former Johnson & Johnson clinical trial head-researcher and journal peer reviewer. Dr Wiseman with his small but dedicated team have masterfully compiled a series of slides analysing the data from Israel, UK, Denmark and Canada for the Pfizer-BioNTech Covid vaccine comparing vaccine effectiveness of the primary series of vaccination (dose 1 and 2) with the booster. What he revealed in his analysis of the data was highly alarming and raised many red flags of negative vaccine efficacy and its implications- where the vaccines are doing more harm than good.

Join The Conversation! | https://trialsitenews.com/ Jeffrey R. Holt, Ph.D. is a professor of otolaryngology & neurology, director of research, otolaryngology at the F.M. Kirby Neurobiology Center, Boston Children's Hospital and is on the Harvard Medical School and Harvard-MIT Health Sciences Technology Faculty. You can read his paper in Science Advances here: Links | https://www.science.org/doi/10.1126/sciadv.abi7629

Join The Conversation! | https://trialsitenews.com/ Story 1 | ‘There is no Control of the Omicron Wave’ as Heavily Pfizer-Boosted Nation Shatters Infection Record The omicron variant of SARS-CoV-2 rages now through the eastern Mediterranean nation of Israel as the reported number of cases hit a COVID-19 pandemic record of 17,362 new infections on Monday, January 5th. As TrialSite just reported, a fourth booster program commences, targeting higher risk demographics such as the elderly and immunocompromised. Article Link | https://trialsitenews.com/there-is-no-control-of-the-omicron-wave-as-heavily-pfizer-boosted-nation-shatters-infection-record/ Story 2 | Doctor In Pennsylvania Fired for Not Taking Covid Vaccine In another instance of a COVID-19-based division in the medical community, a doctor has been fired over his refusal to be vaccinated. According to HealthCareBusiness News, Dr. Joseph Auteri, who was the chief cardiovascular surgeon, was fired by Doylestown Hospital for his refusal to comply with the hospital’s vaccine mandate. Auteri was also the medical director of Doylestown Health’s Woodall Center for Heart and Vascular Care in Doylestown, Pennsylvania. Article Link | https://trialsitenews.com/doctor-in-pennsylvania-fired-for-not-taking-covid-vaccine/

Join The Conversation! | https://trialsitenews.com/ Story 1 | ‘There is no Control of the Omicron Wave’ as Heavily Pfizer-Boosted Nation Shatters Infection Record The omicron variant of SARS-CoV-2 rages now through the eastern Mediterranean nation of Israel as the reported number of cases hit a COVID-19 pandemic record of 17,362 new infections on Monday, January 5th. As TrialSite just reported, a fourth booster program commences, targeting higher risk demographics such as the elderly and immunocompromised. Article Link | https://trialsitenews.com/there-is-no-control-of-the-omicron-wave-as-heavily-pfizer-boosted-nation-shatters-infection-record/ Story 2 | Doctor In Pennsylvania Fired for Not Taking Covid Vaccine In another instance of a COVID-19-based division in the medical community, a doctor has been fired over his refusal to be vaccinated. According to HealthCareBusiness News, Dr. Joseph Auteri, who was the chief cardiovascular surgeon, was fired by Doylestown Hospital for his refusal to comply with the hospital’s vaccine mandate. Auteri was also the medical director of Doylestown Health’s Woodall Center for Heart and Vascular Care in Doylestown, Pennsylvania. Article Link | https://trialsitenews.com/doctor-in-pennsylvania-fired-for-not-taking-covid-vaccine/

Join The Conversation! | https://trialsitenews.com/ While many people just assume biotech investors make big returns during the pandemic, perhaps nothing could be farther from the truth for many investors in this traditionally high volatile market. Recently, the Wall Street Journal reported that “The performance of the biotech sector this year is worse than all 11 of the S&P 500’s sectors.” Biotech stock prices overall have fallen after 2019 and 2020 surges. While some biotech and pharma companies were “winners,” most have missed out on the opportunity to monetize the pandemic. Looming questions and issues mount—spooking potential investors—which, of course, can adversely impact share prices. Do some noticeable losses in hedge funds introduce more risk or opportunity?

Join The Conversation! | https://trialsitenews.com/ While many people just assume biotech investors make big returns during the pandemic, perhaps nothing could be farther from the truth for many investors in this traditionally high volatile market. Recently, the Wall Street Journal reported that “The performance of the biotech sector this year is worse than all 11 of the S&P 500’s sectors.” Biotech stock prices overall have fallen after 2019 and 2020 surges. While some biotech and pharma companies were “winners,” most have missed out on the opportunity to monetize the pandemic. Looming questions and issues mount—spooking potential investors—which, of course, can adversely impact share prices. Do some noticeable losses in hedge funds introduce more risk or opportunity?

Dr. Boulware is an infectious disease expert and researcher at the University of Minnesota. He is one of the lead investigators of the COVID-OUT clinical trial which is testing three drugs and combinations of those drugs as early treatment for COVID-19. Links | https://covidout.umn.edu/

Dr. Klausner is an infectious disease expert and epidemiologist. You can read his full bio here: https://keck.usc.edu/faculty-search/jeffrey-klausner/

Join The Conversation! | https://trialsitenews.com/ Dr. Klausner is an infectious disease expert and epidemiologist. You can read his full bio here | https://keck.usc.edu/faculty-search/jeffrey-klausner/

Join The Conversation! | https://trialsitenews.com/ The U.S. Food and Drug Administration (FDA) is coming for any physician or pharmacy that promotes ivermectin as a drug that can “prevent Coronavirus Disease 2019.” Recently, FDA Acting Branch Chief Shannon Glueck wrote a letter to the Federation of State Medical Boards informing them that they have received complaints that the antiparasitic drug was being offered for sale with claims that it could treat or prevent the novel coronavirus. The FDA is now putting licensing boards on notice. Letter from the FDA | https://trialsitenews.com/wp-content/uploads/2021/12/Ivermectin-Letter-to-FSMB-Final.pdf

Join The Conversation! | https://trialsitenews.com/ The U.S. Food and Drug Administration (FDA) is coming for any physician or pharmacy that promotes ivermectin as a drug that can “prevent Coronavirus Disease 2019.” Recently, FDA Acting Branch Chief Shannon Glueck wrote a letter to the Federation of State Medical Boards informing them that they have received complaints that the antiparasitic drug was being offered for sale with claims that it could treat or prevent the novel coronavirus. The FDA is now putting licensing boards on notice. Letter from the FDA | https://trialsitenews.com/wp-content/uploads/2021/12/Ivermectin-Letter-to-FSMB-Final.pdf Join us on Rumble! | https://rumble.com/user/TrialSiteNews 0:00 Intro 0:15 House Cleaning Update 3:06 FDAComing After Doctors

In this must watch edition of CATalyst, Dr David Wiseman ( PhD Research Bioscientist who was one of the top research scientists at Johnson & Johnson) joins Shabnam Palesa Mohamed for a riveting discussion on US VAERS (Vaccine Adverse Events Reporting System) data that the public has a right to know about. During this informative and often shocking interview, we unpack the second expert letter written to the ACIP (Advisory Committee on Immunisation Practices) by Dr Wiseman and Dr Jessica Rose, Dr Josh Guetzkow and Dr Hervé Seligmann. This urgent letter raises critical issues on vaccine safety, and transparency concerns with regards to ACIP meetings:“Given the circumstances of how the December 16 meeting was announced, concerns about opacity are deepened. Like before, the late notice, the late-publication of a docket number, the failure of email notifications, and late posting of presentation slides, require corrective action.” In the second letter to ACIP by these experts, the data-driven views on the vaccines include: a) Contraindications are warranted for all quasi-vaccines, to include other events (thrombosis, myocarditis, etc.). b) Focusing on a small subset of events in one quasi-vaccine is regulatory misdirection. c) There is insufficient guidance on coagulopathies for Janssen and other quasi-vaccines. d) COVID-19 quasi-vaccine in children 5-11 years: Urgent contraindication and re-evaluation of use is warranted. e) ACIP should be discussing ever reduced benefit for greater risk of the quasi-vaccine rollout. f) Attempting to boost our way out of new variants is the immunological equivalent of heroin addiction. g) A full review of the existing EUAs and BLA is warranted - due to greater prevalence of adverse effects, as well as death far exceeding the TTS rate for Janssen, and the death reports for all three Covid-19 quasi-vaccines. Dr Wiseman asks: Why aren't the regulators doing anything about the data being presented? He also answers questions on regulatory misdirection, whether what is going on is scientific fraud, and what a full review of the quasi-vaccines would look like. We also talk about the importance of ethical scientists and industry whistleblowers. Finally, he offers advice to the public about engaging with science to make informed decisions, and going to law makers and media to make your voice heard.

Join The Conversation! | https://trialsitenews.com/ Dr. Abbott discusses his research on plants used by Native Americans for years and their mechanisms of action for reducing pain and serving as digestive aids. Links to his bio and his study discussed in this interview are here: Study | https://www.frontiersin.org/articles/10.3389/fphys.2021.777057/full?fbclid=IwAR3ZJXgIzNaAaeZVDsTpwiXK7SQFpKJK39ZnwNARgZQPe-wt-TBUMp4or60 Bio | https://www.faculty.uci.edu/profile.cfm?faculty_id=5869

“The Magic Mushroom” – or its key ingredient, Psilocybin – appears to be out in the lead in the modern wave of psychedelic research. Alongside the high-profile Phase II trial results from Compass Pathways (CMPS, profiled previously on TrialSite News), a handful of other early studies are progressing, or close to starting: Usona Institute, Filament Health, Numinus (NUMI), Diamond Therapeutics, TheraPsil.

Join The Conversation! | https://trialsitenews.com/ “The Magic Mushroom” – or its key ingredient, Psilocybin – appears to be out in the lead in the modern wave of psychedelic research. Alongside the high-profile Phase II trial results from Compass Pathways (CMPS, profiled previously on TrialSite News), a handful of other early studies are progressing, or close to starting: Usona Institute, Filament Health, Numinus (NUMI), Diamond Therapeutics, TheraPsil.

Dr. Sigal Kremer-Tal is the Chief Medical and Regulatory Officer of MigVax Ltd based in Israel. Link | https://www.migvax.com/

1131 children aged 12–15-years-old were enrolled in Pfizer’s clinical trial of their mRNA based Covid vaccine. Maddie was one of them. Stephanie, her mother, shares Maddie’s heart-wrenching story with Sonia Elijah for Trial Site News.

Dave Hanaman is president of Curavit Clinical Research https://curavitclinicalresearch.com/

Dr. David Wiseman talks about Molnupiravir and FDA Advisory Committee with Dr. Erin

Dr. Greta Wood is a medical doctor and a clinical research fellow at the University of Liverpool working on the COVID-CNS study. Link: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/team/

Dr. Pierre Pellier is CEO of CTMA a biotech using technology to transform clinical trial patient recruitment and make it more effective for patients. CTMA link: https://www.ctma.fr/about/the-team/

had the pleasure of interviewing Dr Robert Malone, inventor of mRNA technology and vaccine expert, for the second time. Malone revealed the alarming counts of censorship by the scientific journals and the major conflicts of interest at play. He exposed “another way the pharmaceutical industry can exert influence by bending the law.” Dr Malone spoke how Covid vaccine companies are being given special treatment by the FDA and that “the manipulation of the data is occurring on multiple levels.” He spoke about the strong disincentives for doctors to report vaccine adverse events to VAERS and explained the term “plausible deniability” in the context of why the CDC denies that there are any vaccine-related deaths.

Join The Conversation! | https://trialsitenews.com/ Dr. Nikolai Petrovsky, a renowned researcher, professor and expert in the field of immunology, endocrinology and vaccine development speaks about the shocking Covid-19 restrictions that have tightened around Australia. Dr. Petrovsky is the founder of the vaccine company, Vaxine, funded by the US NIH to develop novel vaccine technologies. He has developed a protein subunit vaccine for COVID-19. He also serves as director of endocrinology at Flinders Medical Centre, Australia, and is vice-president and secretary-general of the international immunomics society. See the full interview here | https://www.youtube.com/watch?v=BNfyx218i_E Vaxine Website Link | https://vaxine.net/

Join The Conversation! | https://trialsitenews.com/ Dr. Nikolai Petrovsky, a renowned researcher, professor and expert in the field of immunology, endocrinology and vaccine development speaks about the shocking Covid-19 restrictions that have tightened around the country. Dr. Petrovsky is the founder of the vaccine company, Vaxine, funded by the US NIH to develop novel vaccine technologies. He has developed a protein subunit vaccine for COVID-19. He also serves as director of endocrinology at Flinders Medical Centre, Australia, and is vice-president and secretary-general of the international immunomics society. See the full interview here | https://www.youtube.com/watch?v=BNfyx218i_E Link | https://vaxine.net/

Part 1 of my investigative series focused on the sudden removal of a published, peer-reviewed paper on vaccine-induced myocarditis based on US VAERS data, authored by Dr Peter McCullough, MD, MPH, and Dr Jessica Rose Ph.D., by Elsevier and Current Problems in Cardiology. Part 2 centers on my revelatory interview with Dr Pierre Kory MD, an expert critical care physician and pulmonary (lung) specialist. Dr Kory is a world pioneer in the use of ultrasound in the diagnosis and treatment of critically ill patients. He is also the co-founder and president of FLCCC (Frontline Covid-19 Critical Care Alliance).